The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain information on PK/PD, efficacy and safety of SHR3824
over 12 weeks in Chinese patients with Type 2 Diabetes. This will be done by comparing the
effect of SHR3824 to placebo when given in oral doses.